Iłzecka J
Department of Neurology, Medical University of Lublin, Lublin, Poland.
Scand J Clin Lab Invest. 2007;67(3):264-9. doi: 10.1080/00365510601016105.
There is evidence showing impaired mitochondrial energy production and increased oxidative damage to mitochondria in amyotrophic lateral sclerosis (ALS). It is known that a lack of cytochrome c (CyC) in the mitochondrial intermembrane space can increase free radical release from mitochondria through interruption of the electron transport. CyC also plays a role in the apoptotic cell death which is suspected in ALS. The aim of the study was to measure cerebrospinal fluid (CSF) and serum CyC levels in patients with ALS.
Forty ALS patients were diagnosed according to the El Escorial criteria of ALS. The clinical state of the patients was measured using the Amyotrophic Lateral Sclerosis Functional Rating Scale [ALSFRS].
It was shown that overall CyC levels were significantly decreased by 46 % in the CSF of patients with ALS compared with controls (p<0.05), and not affected in serum of patients with ALS (p>0.05). There was no significant difference in CyC levels in relation to the clinical parameters of the disease (p>0.05).
The study indicates that CyC may play a role in the pathogenesis of ALS. A possible mechanism is that increased neurodegeneration in ALS caused by free radical production decreases the concentrations of CyC.
有证据表明,肌萎缩侧索硬化症(ALS)患者存在线粒体能量生成受损以及线粒体氧化损伤增加的情况。已知线粒体内膜间隙中细胞色素c(CyC)的缺乏会通过中断电子传递增加线粒体自由基的释放。CyC在疑似ALS的凋亡性细胞死亡中也起作用。本研究的目的是测量ALS患者脑脊液(CSF)和血清中CyC的水平。
根据ALS的埃尔埃斯科里亚尔标准诊断出40例ALS患者。使用肌萎缩侧索硬化症功能评定量表[ALSFRS]对患者的临床状态进行测量。
结果显示,与对照组相比,ALS患者脑脊液中CyC的总体水平显著降低了46%(p<0.05),而ALS患者血清中的CyC水平未受影响(p>0.05)。CyC水平与疾病的临床参数之间无显著差异(p>0.05)。
该研究表明CyC可能在ALS的发病机制中起作用。一种可能的机制是,ALS中由自由基产生导致的神经变性增加会降低CyC的浓度。